Titan Pharmaceuticals
TTNP
#11013
Rank
โ‚น0.58 B
Marketcap
โ‚น442.01
Share price
-3.76%
Change (1 day)
26.41%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น420.91. In 2023 the company made an earnings per share (EPS) of -โ‚น710.47 an increase over its 2022 EPS that were of -โ‚น1,456.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น710.47-51.22%
2022-โ‚น1,456-15.61%
2021-โ‚น1,726-81.37%
2020-โ‚น9,262-77.52%
2019-โ‚น41,209-56.32%
2018-โ‚น94,347-59.51%
2017-โ‚น2,33,037-371.81%
2016โ‚น85,735-144.35%
2015-โ‚น1,93,296300%
2014-โ‚น48,324-121.54%
2013โ‚น2,24,361-151.38%
2012-โ‚น4,36,641-11.54%
2011-โ‚น4,93,595188.89%
2010-โ‚น1,70,860-10%
2009-โ‚น1,89,844
2007-โ‚น7,78,361-2.38%
2006-โ‚น7,97,345-39.13%
2005-โ‚น13,09,924-16.87%
2004-โ‚น15,75,706-22.43%
2003-โ‚น20,31,3324.9%
2002-โ‚น19,36,41061.9%
2001-โ‚น11,96,018-13.7%
2000-โ‚น13,85,86265.01%
1999-โ‚น8,39,879-35.87%
1998-โ‚น13,09,701-1824.71%
1997โ‚น75,938-102.4%
1996-โ‚น31,70,397

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น837.48-298.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น673.08-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น388.31-7.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น88.21-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น23.01-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น408.45-2.96%๐Ÿ‡บ๐Ÿ‡ธ USA